Anaphylaxis in the New Millennium
Anaphylaxis continues to challenge patients and healthcare providers because of the variety of ways it can manifest. This course - a recording of a plenary session presented at the AAAAI 2012 Annual Meeting in Orlando, FL - reviews the immunologic mechanisms of anaphylaxis, including non-IgE mediated anaphylaxis; reasons the heart is an important target in the diagnosis and management of anaphylaxis; and summarizes the assessment and management guidelines for anaphylaxis from the World Allergy Organization.
The Anaphylaxis Identification and Management (AIM) initiative is funded through an educational grant from sanofi-aventis, U.S.
Allied health providers working in allergy/immunology clinics
Healthcare providers treating patients at risk of an anaphylactic reaction
Upon completion of this session, participants should be able to:
1. Describe immunologic mechanisms in anaphylaxis, including non-IgE-mediated
2. Explain why the heart is an important target
3. State the unique principles of anaphylaxis assessment and management promulgated in the World Allergy Organization Anaphylaxis Guidelines.
Vivian P. Hernandez-Trujillo, MD FAAAAI
Miami Children's Hospital (Director, Division of Allergy/Immunology)
Stephen J. Galli, MD
Stanford University School Medicine (Chair, Dept of Pathology)
Dean D. Metcalfe, MD FAAAAI
NIAID/NIH (Chief, Lab Allergic Diseases)
F. Estelle R. Simons, MD FAAAAI
University of Manitoba (Professor, Section of Allergy and Clinical Immunology)
- 1.50 AttendanceAttendance credit.
- 1.80 CECE credit.
- 1.50 CMECME credit.